T cell recruitment into the GBM TME is primarily driven by chemokine such as C-X-C motif chemokine ligand (CXCL) 10, which attract CD8+ T cell and effector memory T-cells, to enhance the efficacy of immunotherapies and improve therapeutic outcomes [102]. Here, CD8A is linked to glioblastoma.